Who Is on Your MPN Healthcare Team?
https://vimeo.com/565833881 Who are the key members of the myeloproliferative neoplasm (MPN) healthcare team? Dr. Naveen Pemmaraju discusses the team members he recommends in the modern era for optimal care for…
Myeloproliferative Neoplasms Defined: What Are ET, PV, and MF?
https://vimeo.com/565834148 What are essential thrombocythemia (ET) , polycythemia vera (PV), and myelofibrosis (MF) exactly? Dr. Naveen Pemmaraju explains how each of these blood disorders manifests along with the symptoms observed…
Is the COVID-19 Vaccine Safe and Effective for MPN Patients?
https://vimeo.com/565831433 Is the COVID-19 vaccine effective and safe for myeloproliferative neoplasm (MPN) patients? Dr. Naveen Pemmaraju shares information about the safety and effectiveness of COVID-19 vaccines and specific medical data…
How to Make an Informed MPN Treatment Decision
https://vimeo.com/567196481 When faced with several options, how can you decide on the best therapy for your essential thrombocythemia (ET), polycythemia vera (PV), or myelofibrosis (MF)? In this explainer video, Katrina…
How to Play an Active Role in Your MPN Treatment and Care Decisions
https://vimeo.com/557743362 How can you play a role in your MPN care and treatment decisions? Engaging with your healthcare team is essential and may lead to better overall outcomes. In this…
What’s YOUR Role in Making Myelofibrosis Treatment Decisions?
https://vimeo.com/527911164 How can you play a role in your myelofibrosis care? Dr. Joseph Scandura shares his personal philosophy on patient care and the important role of shared decision-making. Dr. Joseph…
Expert Perspective: Promising Myelofibrosis Treatment Research
https://vimeo.com/527911338 Dr. Joseph Scandura shares optimism about myelofibrosis therapy in clinical trials, including excitement about anti-fibrotic agents and how they work. Dr. Joseph Scandura is Associate Professor of Medicine and…
COVID-19 Vaccination: What Do Myelofibrosis Patients Need to Know?
https://vimeo.com/527911668 Should myelofibrosis patients get the COVID-19 vaccine? Dr. Joseph Scandura discusses the risks and benefits of vaccination. Dr. Joseph Scandura is Associate Professor of Medicine and Scientific Director of…
What Are the Considerations When Choosing Myelofibrosis Therapy?
https://vimeo.com/527911461 When choosing a myelofibrosis treatment, how do you determine what might be best for you? Dr. Joseph Scandura shares expert advice, including a review of inhibitor therapy and stem…
Primary vs. Secondary Myelofibrosis: What’s the Difference?
https://vimeo.com/527912323 Are primary and secondary myelofibrosis different? Dr. Joseph Scandura, a specialist in myeloproliferative neoplasms (MPNs), explains the diagnoses and shares insight into each type. Dr. Joseph Scandura is Associate…
How Does Inhibitor Therapy Work to Treat Myelofibrosis?
https://vimeo.com/527911823 What is inhibitor therapy? Dr. Joseph Scandura reviews approved JAK inhibitor therapies and explains how they work to treat myelofibrosis. Dr. Joseph Scandura is Associate Professor of Medicine and…
Which Gene Mutations Impact Myelofibrosis Treatment Options?
https://vimeo.com/527911939 Are there specific mutations that may affect myelofibrosis treatment choices? Dr. Joseph Scandura explains the factors that are considered when deciding a myelofibrosis therapy, including a discussion of high-risk…